Abstract
Non-valvular atrial fibrillation (NVAF) is often accompanied by multiple comorbid conditions, which increase the associated risks and complexity of patient management. This study evaluated the risk of stroke/systemic embolism (SE) and major bleeding (MB) among multimorbid patients with NVAF who were prescribed non-vitamin K antagonist oral anticoagulants (NOACs) or warfarin. A retrospective study of patients with NVAF and high multimorbidity who initiated apixaban, dabigatran, rivaroxaban, or warfarin from 1 January 2013 to 30 September 2015 was conducted using five insurance claims databases. Multimorbidity was defined as six or more comorbid conditions, and 1:1 propensity score matching (PSM) was conducted between the NOAC-warfarin and NOAC-NOAC cohorts. Cox proportional hazard models were used to evaluate the hazard ratios of stroke/SE and MB. Of the NVAF population (n = 466,991), 33.4% (n = 155,959) had multimorbidity, including 36,921 apixaban, 10,248 dabigatran, 45,509 rivaroxaban, and 63,281 warfarin patients. Compared to warfarin, apixaban and rivaroxaban were associated with a lower risk of stroke/SE (hazard ratio [HR] 0.63, 95% CI 0.54-0.74; HR 0.70, 95% CI 0.64-0.77, respectively). Apixaban and dabigatran were associ...Continue Reading
References
Jan 1, 1987·Journal of Chronic Diseases·M E CharlsonC R MacKenzie
Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Sep 17, 2009·Statistics in Medicine·Peter C Austin
Mar 10, 2011·Pharmacoepidemiology and Drug Safety·Andrew CunninghamWayne A Ray
Feb 2, 2013·Epidemiologic Reviews·Marcel E Salive
Sep 17, 2013·Pituitary·M S BroderL Katznelson
Oct 15, 2013·Statistics in Medicine·Peter C Austin
Nov 15, 2013·Thrombosis and Haemostasis·Raffaele De CaterinaJeffrey I Weitz
Dec 10, 2013·Lancet·Christian T RuffElliott M Antman
Jun 27, 2014·Clinical Epidemiology·Massimo Zoni-BerissoStefano Domenicucci
Jan 15, 2015·Circulation. Cardiovascular Quality and Outcomes·Jonathan L ThigpenNita A Limdi
Mar 30, 2016·BMC Cardiovascular Disorders·Vigdis VanbeselaereBert Vaes
Apr 27, 2016·Clinics in Geriatric Medicine·Anna L Parks, Margaret C Fang
Mar 17, 2017·Thrombosis and Haemostasis·Xiaoyan Shawn LiGregory Y H Lip
Nov 8, 2017·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Bhautesh Dinesh JaniFrances S Mair
Dec 21, 2018·Stroke; a Journal of Cerebral Circulation·Gregory Y H LipSteven Deitelzweig
Dec 24, 2018·American Heart Journal·Karen P AlexanderUNKNOWN ARISTOTLE Investigators
Jan 16, 2019·JAMA Network Open·Amgad MentiasMary S Vaughan Sarrazin
Feb 1, 2019·Journal of the American College of Cardiology·Craig T JanuaryClyde W Yancy
Nov 2, 2019·Mayo Clinic Proceedings·Marco ProiettiAlessandro Nobili
Jan 28, 2021·Circulation·Salim S ViraniUNKNOWN American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee